The World Health Organization (WHO) estimates that about 10 per cent of global pharmaceutical supply is counterfeit and substandard.
The percentage of substandard medicines in Sub-Saharan Africa is even higher, if we are to go by the figure indicated in the Journal of Pharmaceutical Policy Practise published in November 2016. In an article published under the title, fighting poor-quality medicines in low and middle income countries: the importance of advocacy and pedagogy, 34 per cent of medicines in Sub-Saharan Africa are of poor quality.